|Primary analysis complete
|Study Start Date:
|Study Made Public:
A Phase 1 trial to evaluate the safety, tolerability, and immunogenicity of an IL-12 pDNA enhanced HIV-1 multiantigen pDNA vaccine delivered intramuscularly with electroporation, with an HIV-1 rVSV vaccine boost, in healthy HIV-unifected adult participants
HVTN 087 is a Phase I clinical trial to evaluate the safety and immunogenicity of prime/boost regimens using combinations of HIV-1 multiantigen pDNA, IL-12 plasmid adjuvant, and HIV-1 rVSV.
Sign in to see full information about this study and to download study data.
ProductsProduct info coming soon!
No integrated data is available for this study.
No non-integrated data is available for this study.